NYSE:LAZCapital Markets
Lazard Adds Senior Healthcare Leaders As Shares Screen Undervalued
Lazard has expanded its Healthcare Group with the addition of senior Managing Directors John Koski and Rob Lowe.
Both hires bring extensive experience in healthcare advisory and leadership from established firms.
Lazard, listed as NYSE:LAZ, is putting more weight behind its healthcare advisory franchise by hiring John Koski and Rob Lowe into its Healthcare Group. The stock last closed at $48.39, with a 1 year return of 4.2% and a 3 year return of 49.9%. Over 5 years, the share price return...